← back to search

David Redmond

Cornell University · US
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immune Cell Function and Interaction, and Immunotherapy and Immune Responses.
h-index
36
citations
6,114
works
137
NIH funding
primary concept
Medicine
email

Recent publications

Microenvironmental determinants of endothelial cell heterogeneity
Nature Reviews Molecular Cell Biology 2025cited by 36position: middledoi
Suppression of thrombospondin-1–mediated inflammaging prolongs hematopoietic health span
Science Immunology 2025cited by 11position: middledoi
ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels
Circulation 2024cited by 16position: middledoi
Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Nature 2024cited by 3position: middledoi
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
Cell 2023cited by 290position: middledoi
Restoring bone marrow niche function rejuvenates aged hematopoietic stem cells by reactivating the DNA Damage Response
Nature Communications 2023cited by 42position: middledoi
Profiling Germinal Center-like B Cell Responses to Conjugate Vaccines Using Synthetic Immune Organoids
ACS Central Science 2023cited by 24position: middledoi
Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection
JCI Insight 2022cited by 122position: middledoi
Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy
iScience 2022cited by 96position: middledoi
Specification of fetal liver endothelial progenitors to functional zonated adult sinusoids requires c-Maf induction
Cell stem cell 2022cited by 80position: middledoi
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
The Journal of Experimental Medicine 2022cited by 47position: middledoi
Cooperative ETS transcription factors enforce adult endothelial cell fate and cardiovascular homeostasis
Nature Cardiovascular Research 2022cited by 30position: middledoi
Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate
Proceedings of the National Academy of Sciences 2021cited by 221position: middledoi
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Cell Metabolism 2021cited by 200position: middledoi
Reversal of emphysema by restoration of pulmonary endothelial cells
The Journal of Experimental Medicine 2021cited by 90position: middledoi
An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts
Circulation Research 2021cited by 86position: middledoi
SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling
Cell stem cell 2021cited by 70position: middledoi
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2
Stem Cell Reports 2021cited by 58position: middledoi
Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells: Current Controversies
Frontiers in Physiology 2021cited by 57position: middledoi
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
Cell stem cell 2020cited by 673position: middledoi
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Nature 2020cited by 538position: middledoi
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
Nature 2020cited by 337position: middledoi
Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis
Nature 2020cited by 253position: middledoi
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
Nature Communications 2020cited by 70position: middledoi
Molecular determinants of nephron vascular specialization in the kidney
Nature Communications 2019cited by 140position: middledoi
Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer
Cell Reports 2019cited by 72position: middledoi
AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis
Nature Communications 2018cited by 74position: middledoi
Conversion of adult endothelium to immunocompetent haematopoietic stem cells
Nature 2017cited by 226position: middledoi
EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop
Nature Communications 2017cited by 184position: middledoi
Single-cell TCRseq: paired recovery of entire T-cell alpha and beta chain transcripts in T-cell receptors from single-cell RNAseq
Genome Medicine 2016cited by 147position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Shahin Rafii · California Institute for Regenerative Medicine10 papers (2017–2025)Sean Houghton · Cornell University9 papers (2019–2022)Olivier Elemento · Cornell University9 papers (2014–2020)Jenny Xiang · Cornell University6 papers (2017–2022)Ari Melnick · Cornell University5 papers (2014–2018)Raphaël Lis · California Institute for Regenerative Medicine5 papers (2017–2022)Tyler M. Lu · SUNY Downstate Health Sciences University5 papers (2019–2022)Jesús M. Gómez-Salinero · California Institute for Regenerative Medicine4 papers (2019–2025)Yaron Bram · Cornell University3 papers (2021–2022)Jason M. Butler · Royal Brisbane and Women's Hospital3 papers (2017–2025)Robert E. Schwartz · Cornell University3 papers (2021–2022)Balvir Kunar · Cornell University3 papers (2017–2021)Wayne Tam · Donald & Barbara Zucker School of Medicine at Hofstra/Northwell3 papers (2014–2015)Ryan Schreiner · California Institute for Regenerative Medicine3 papers (2021–2022)Rita Shaknovich · Meta (United States)3 papers (2015–2018)Michael G. Poulos · University of Florida3 papers (2017–2025)Giorgio Inghirami · Cornell University3 papers (2015–2022)Matt Teater · Cornell University3 papers (2015–2018)José Gabriel Barcia Durán · New York University3 papers (2017–2021) · 2 papers (2023–2025)